After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
PharmaCyte Biotech Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of PharmaCyte Biotech Inc is $9.49M. A total of 0.6 million shares were traded on the day, compared to an average of 3.40M shares.
In the most recent transaction, Silverman Joshua bought 40,000 shares of PMCB for 0.83 per share on Jan 07 ’26. After the transaction, the CEO and President now owns 416,250 company shares. In a previous transaction on Jan 06 ’26, Silverman Joshua bought 30,000 shares at 0.79 per share. PMCB shares that CEO and President owns now total 376,250.
Among the insiders who bought shares, Silverman Joshua acquired of 30,000 shares on Jan 05 ’26 at a per-share price of $0.78. This resulted in the CEO and President holding 346,250 shares of PMCB after the transaction. In another insider transaction, SCHECHTER JONATHAN bought 20,000 shares at $0.84 per share on Jan 07 ’26. Company shares held by the Director now total 192,500.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, PMCB has a high of $1.90 and a low of $0.63.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. PMCB’s latest balance sheet shows that the firm has $85.40M in Cash & Short Term Investments as of fiscal 2022. Its Book Value Per Share was $5.18, while its Total Shareholder’s Equity was $89.92M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
